News

Since 2022, the DEA has capped the amount of pills that ADHD drug manufacturers — like Adderall maker Teva Pharmaceuticals, Vyvanse maker Takeda, and Ritalin maker Novartis — are allowed to ...
PARSIPPANY, N.J. & REYKJAVÍK, Iceland, May 05, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE ...
These survey results were presented by Teva as part of a large set of schizophrenia data at the SIRS 2025, taking place from March 29 to April 2 in Chicago (Teva’s press release). (De novo ...
Australian children and teenagers face the biggest impacts of an international shortage of critical ADHD medications. The nation's health regulator says certain drugs used to treat attention deficit ...